Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Southern Company (SO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Southern Company — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Southern Company trades at $86.03 (market cap $98.29B). The key difference: Southern Company is far larger — about 20.9× Definium Therapeutics Inc. Common Shares's market cap, and Southern Company pays a 3.56% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Southern Company for 12 Days on average.
| DFTX | SO | |
|---|---|---|
Market Cap | $4.71B | $98.29B |
Volume | 1,966,636 | 5,624,994 |
Sector | Health | Utilities |
52-Week High | $48.45 | $99.72 |
52-Week Low | $10.68 | $82.35 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $3.67B | $172.39B |
Dividend Yield | — | 3.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Southern Company
Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.
Read more on SO →
